Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)
Status:
Completed
Trial end date:
2021-07-23
Target enrollment:
Participant gender:
Summary
This study will evaluate the long-term efficacy and safety of low dose oral
methylprednisolone compared to matching placebo, on a background of routine RAS inhibitor
therapy, in preventing kidney events in patients with IgA nephropathy and features suggesting
a high risk of progression.